U.S. Semiconductors Stock News

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

McCormick & Company, Incorporated ( NYSE:MKC ) stock is about to trade ex-dividend in 3 days. Typically, the...

OmniAb, Inc.'s ( NASDAQ:OABI ) price-to-sales (or "P/S") ratio of 11.4x may look like a poor investment opportunity...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...

Golden Entertainment, Inc. ( NASDAQ:GDEN ) shareholders might understandably be very concerned that the share price has...

There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...

Santech Holdings Limited ( NASDAQ:STEC ) shares have retraced a considerable 53% in the last month, reversing a fair...

Despite an already strong run, Sunrun Inc. ( NASDAQ:RUN ) shares have been powering on, with a gain of 27% in the last...

With a price-to-earnings (or "P/E") ratio of 23.5x Middlesex Water Company ( NASDAQ:MSEX ) may be sending bearish...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Helen of Troy (HELE) remains in the red, with losses worsening at an annualized rate of 42% over the last five years. Looking ahead, forecasts point to continued unprofitability for at least the next three years, while revenue is expected to edge up just 1% annually, which is below the US market’s 9.9% average. Despite this sluggish outlook, HELE stands out for its discounted Price-to-Sales Ratio of 0.3x, significantly lower than both its industry and peer averages. This could attract...

Biomea Fusion (BMEA) has completed a $25 million equity offering following the release of data from its Phase II COVALENT-111 trial. The study showed sustained HbA1c reduction in type 2 diabetes patients. See our latest analysis for Biomea Fusion. Biomea Fusion’s stock has been notably volatile. Shares initially jumped on the back of encouraging Phase II clinical data, but quickly reversed and dropped sharply after the $25 million equity offering was announced. With the latest share price at...

Neogen (NEOG) is forecast to grow revenue at just 0.9% per year, lagging well behind the broader US market, which is expected to expand at 9.9% annually. The company remains unprofitable, with losses increasing at a rapid 90.4% annual pace over the past five years and no improvement in net profit margins. Looking ahead, Neogen is projected to remain in the red for at least the next three years. With discounted cash flow analysis off the table due to insufficient data, investors are likely to...

Bassett Furniture Industries (BSET) has returned to profitability, reporting an improved net profit margin over the last year. While earnings have grown at an average rate of -12.6% per year over the past five years, the company is now forecast to grow earnings by 27% annually going forward, outpacing the broader US market’s expected 15.4% growth rate. With top-line expansion expected to lag at 3.5% per year compared to the US market’s 9.9%, the company’s strong earnings quality and...

If you are trying to decide what to do with Ducommun stock, you are not alone. Many investors are weighing their options right now, wondering if the incredible run-up has more room to go or if it is time to be cautious. The numbers are certainly eye-catching: in just the last week, Ducommun climbed 2.9%, and over 30 days it added an impressive 8.3%. Year-to-date and over the past year, the stock has soared by more than 52% and 54% respectively. Looking even further back, that is a 131.1% gain...

Thinking about what to do with PAR Technology stock right now? You are definitely not alone. The company has been drawing attention with its rollercoaster stock performance. There have been some bumps lately, but the larger story is much more interesting for investors with their eyes on value. Over just the past week, shares dipped by 1.5%, extending a tough 30 days that saw the stock slide nearly 20%. Year to date, that drop has stretched to more than 47%, and it is down 33.2% over the last...

Tilray Brands (TLRY) remains unprofitable, recording losses that have increased at an average annual rate of 31.4% over the past five years. The company is not expected to turn a profit within the next three years. Revenue growth is projected at just 4.5% per year, which is well behind the US market average of 9.9% per year. With these trends, investors are left weighing potential upside against ongoing risks and limited signs of near-term profit momentum. See our full analysis for Tilray...

Airship AI Holdings (AISP) is in focus after landing 16 new contracts from the Department of Justice and Department of Homeland Security. These $11 million deals represent federal agencies adopting its Outpost AI platform. See our latest analysis for Airship AI Holdings. The sudden wave of new federal contracts seems to have energized Airship AI’s share price, with a 41.3% jump in the past 30 days and a remarkable 192.8% total shareholder return over the last year. That recent momentum marks...

If you are weighing what to do with Universal Technical Institute stock right now, you are not alone. Investors have been buzzing as the stock has not just outperformed in the short term, but also logged massive gains over the past few years. Just take a look at the numbers: up nearly 20% year-to-date, and up an eye-popping 97% over the last year. Stretch out to three or five years and those returns soar past 450%. Even a brief dip of 3.8% in the past week does little to overshadow the...

Constellation Brands (STZ) just posted a meaningful turnaround in profitability, with net profit margin climbing to 12.7% from 5.7% and earnings notching 111% growth over the past year. This bounce contrasts with its five-year track record, where annual earnings had slipped by 11% on average. For investors, the notable recovery is set against forecasts calling for more moderate gains ahead, as revenue is expected to rise just 1.1% annually and earnings by 12.8%. Both measures are pacing...

If you’re staring at OneMain Holdings and wondering whether now is the right time to buy, sell, or hold, you’re not alone. The story here is about more than just this week’s 2.1% dip or the stock’s modest 5.5% year-to-date advance. OneMain Holdings has carved out an impressive long-term run, with a 28.5% return over the past year and an eye-catching 153.8% gain over five years. That kind of performance doesn’t just happen by accident. It reflects a mix of consumer lending trends, ongoing...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...

OneMedNet (ONMD) has drawn attention following new partnerships with Palantir Technologies and Medcase. These moves are intended to expand its reach in healthcare AI, integrate real-time insights, and strengthen its data analytics offerings. See our latest analysis for OneMedNet. OneMedNet’s stock has experienced a remarkable surge lately, with a 171.4% share price return over the past month and an eye-catching 278.9% gain in the last 90 days. This surge has been largely fueled by news of its...

Village Super Market (VLGE.A) has grown earnings by 21.3% per year over the past five years and most recently posted a net profit margin of 2.4%, up from last year’s 2.2%. Last year’s earnings growth came in at 16%, trailing the robust five-year average. Investors are watching closely, as the company’s high quality earnings, strong valuation with a Price-To-Earnings Ratio of 8.2x (well below industry averages), and a track record of profit growth all present attractive reward signals. See our...